We hereby inform you that the trading window for dealing in securities of the Company will remain closed for designated persons of the Company commencing from 1st October, 2024 till expiry of 48 hours after the declaration of unaudited Financial Results of the Company for the quarter ended 30th September, 2024

pdf

Kilitch Drugs(I) Ltd.

21 Sep 2024

362.35

1.73%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation of Issue of Duplicate Share Certificates to shareholders to Stock Exchange under regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Kilitch Drugs(I) Ltd.

13 Sep 2024

362.35

1.73%

Company Update

KILITCH DRUGS (INDIA) LTD. - 524500 - Intimation To Stock Exchange Regarding Report Submitted By Acquirer …

BSE India

intimation to stock exchange regarding report submitted by acquirer to the SEBI under regulation 10(7) of SEBI SAST regulation

pdf

Kilitch Drugs(I) Ltd.

03 Sep 2024

362.35

1.73%

Company Update

KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are submitting herewith the copy of extract of Notice of 32nd AGM published in the newspaper

pdf

Kilitch Drugs(I) Ltd.

02 Sep 2024

362.35

1.73%

Corp. Action

KILITCH DRUGS (INDIA) LTD. - 524500 - Intimation Of Book Closure

BSE India

We hereby inform you that the Register of Members and Register of Share Transfer shall remain closed from Friday, 20th September, 2024 till Friday, 27th September, 2024 for the purpose of AGM

pdf

Kilitch Drugs(I) Ltd.

02 Sep 2024

362.35

1.73%

AGM

KILITCH DRUGS (INDIA) LTD. - 524500 - Notice Of 32Nd Annual General Meeting

BSE India

We are hereby submitting the Notice of 32nd Annual General Meeting of the Company to be held on 27th September, 2024

pdf

Kilitch Drugs(I) Ltd.

02 Sep 2024

362.35

1.73%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Reg. 34 (1) Annual Report.

BSE India

Pursuant to Regulations 34 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015 we are submitting herewith the Annual Report for the Financial Year 2023-24

pdf

Kilitch Drugs(I) Ltd.

30 Aug 2024

362.35

1.73%

Company Update

KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulation, this is to inform you that the Board of Directors at their meeting held today appointed M/s Sharat & Associates, Chartered Accountant as Statutory Auditors of the Company

pdf

No results found

Is Kilitch Drugs(I) Ltd. worth buying?

41 Votes:

Buy 85.37%

Sell 12.2%

Hold 2.44%